Quantitative image analysis of estrogen and progesterone receptors as a prognostic tool for selecting breast cancer patients for therapy

Analytical and Quantitative Cytology and Histology

Volumn 21, Issue 1, 1999, Pages 59-62

  Castagnetta, Luigi A M ^a   Traina, Adele ^b   Liquori, Maurizio ^b   Marasà, Lorenzo ^b   Amodio, Rosalba ^b   Di Falco, Marco ^b   Miele, Monica ^b   Rausa, Luciano ^b   Carruba, Giuseppe ^b  

^a Institute of Oncology   (Italy)

^b NONE

Author keywords

Breast neoplasms; Estrogen receptors; Image analysis, computer assisted; Immunocytochemistry; Progesterone receptors; Prognosis

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; BREAST CANCER; CANCER RECURRENCE; CONFERENCE PAPER; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; MENOPAUSE; PATIENT SELECTION; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE DIAGNOSIS; TREATMENT PLANNING;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PATIENT SELECTION; POSTMENOPAUSE; PREDICTIVE VALUE OF TESTS; PREMENOPAUSE; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 0032979368     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (11)

1. Jensen EV: Steroid hormones, receptors and antagonists. Ann NY Acad Sci 1996;784:1-17
2. Jensen EV, DeSombre ER: Steroid hormone binding and hormone receptors. In Cancer Medicine. Fourth edition. Edited by JF Holland, Frei E III, RC Bast Jr, DW Kufe, DL Morton, RR Weichselbaum. Baltimore, Williams & Wilkins, 1996
3. Pusztay HM, McDonald EM (editors): Symposium on estrogen receptor determination with monoclonal antibodies. Cancer Res 1986;46:4233s-4313s
4. Castagnetta L, Miceli MD, Sorci C, Pfeffer U, Farruggio R, Oliveri G, Calabrò M, Carruba G: Growth of LNCaP cells is stimulated by estradiol via its own receptor. Endocrinology 1995;136:2309-2319
5. Kaplan ER, Meier P: Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958;53:457-481
6. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG: Design and analysis of randomized clinical trials requiring prolonged observation of each patient: Part II. Analysis and examples. Br J Cancer 1977;35:1-39
7. Castagnetta L, Traina A, Di Carlo A, Carruba G, Lo Casto M, Leake RE: Do multiple oestrogen receptor assays give significant additional information for the management of breast cancer? Br J Cancer 1989;59:636-638
8. Castagnetta L, Traina A, Carruba G, Fecarotta E, Palazzotto G, Leake RE: The prognosis of breast cancer patients in relation to the oestrogen receptor status of both primary disease and involved nodes. Br J Cancer 1992;65:167-170
9. DeSombre ER, Greene GL, Jensen EV: Estrophilin and endocrine responsiveness of breast cancer. In Progress in Cancer Research and Therapy. Volume 10: Hormones, Receptors, and Breast Cancer. Edited by WL McGuire. New York, Raven Press, 1978, pp 1-14
10. Pichon MF, Pallud C, Hacene K, Milgrom E: Prognostic value of progesterone receptor after long-term follow-up in primary breast cancer. Eur J Cancer Clin Oncol 1992;28A: 1676-1680
11. Traina A, Liquori M, Cusimano R, Calabria C, Agostara B, Castagnetta L: Recent postmenopause, but not ER status, identifies a subset of primary breast cancer patients with a higher risk of relapse. Ann NY Acad Sci 1996;784:491-195